Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias.

Saved in:

Bibliographic Details
Title:	Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias.
Authors:	Eberlein V; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Rosencrantz S; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Applied Polymer Research (IAP), Potsdam, Germany., Finkensieper J; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Besecke JK; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology (FEP), Dresden, Germany., Mansuroglu Y; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Frankfurt, Germany., Kamp JC; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany., Lange F; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Dressman J; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Frankfurt, Germany., Schopf S; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology (FEP), Dresden, Germany., Hesse C; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany., Thoma M; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Manufacturing Engineering and Automation (IPA), Stuttgart, Germany., Fertey J; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Ulbert S; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Grunwald T; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.
Source:	Frontiers in immunology [Front Immunol] 2024 Apr 05; Vol. 15, pp. 1382318. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2024.1382318